853 related articles for article (PubMed ID: 18564689)
1. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
2. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
3. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
[TBL] [Abstract][Full Text] [Related]
4. Oral Candida isolates among HIV-infected subjects in Nigeria.
Nweze EI; Ogbonnaya UL
J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
[TBL] [Abstract][Full Text] [Related]
5. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
6. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
7. Candida dubliniensis, a new fungal pathogen.
Gutiérrez J; Morales P; González MA; Quindós G
J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
[TBL] [Abstract][Full Text] [Related]
8. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
9. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.
Costa CR; de Lemos JA; Passos XS; de Araújo CR; Cohen AJ; Souza LK; Silva Mdo R
Mycopathologia; 2006 Jul; 162(1):45-50. PubMed ID: 16830191
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
Ruhnke M; Tennagen I; Engelmann E
Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
[TBL] [Abstract][Full Text] [Related]
13. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
14. [Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].
Rodero L; Boutureira M; Demkura H; Burkett A; Fernández C; Losso M; Jáuregui Rueda H; Monticelli A; Vitale R; Canteros C; Hochenfellner F; Vivot W; Davel G
Rev Argent Microbiol; 1997; 29(1):7-15. PubMed ID: 9229726
[TBL] [Abstract][Full Text] [Related]
15. [Oesophageal candidiasis: clinical and mycological analysis].
Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L
Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852
[TBL] [Abstract][Full Text] [Related]
16. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
Fernández Andreu CM; Martínez Machin G; Illnait Zaragozi MT; Perurena Lancha MR; Aguila Sánchez A; Galloso Brito M
Rev Cubana Med Trop; 2007; 59(2):113-8. PubMed ID: 23427444
[TBL] [Abstract][Full Text] [Related]
17. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
[TBL] [Abstract][Full Text] [Related]
18. Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species.
Hung CC; Yang YL; Lauderdale TL; McDonald LC; Hsiao CF; Cheng HH; Ho YA; Lo HJ
J Clin Microbiol; 2005 Apr; 43(4):1600-3. PubMed ID: 15814972
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection].
Masiá Canuto MM; Gutiérrez Rodero F; Ortiz de la Tabla Ducasse V; Martín González C; Escolano Hortelano CM; Mora Rufete A; Martín Hidalgo A
Med Clin (Barc); 1999 Feb; 112(6):211-4. PubMed ID: 10191483
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.
Giammanco GM; Pecorella S; Distefano S; Pecoraro V; Milici ME; Pizzo G
New Microbiol; 2001 Oct; 24(4):397-404. PubMed ID: 11718378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
